Media type: E-Article Title: Hepatitis C antibodies in dialysis patients and patients with leukemia Contributor: Kolho, E.; Oksanen, K.; Honkanen, E.; Naukkarinen, R.; Krusius, T. imprint: Wiley, 1993 Published in: Journal of Medical Virology Language: English DOI: 10.1002/jmv.1890400410 ISSN: 0146-6615; 1096-9071 Keywords: Infectious Diseases ; Virology Origination: Footnote: Description: <jats:title>Abstract</jats:title><jats:p>The prevalence of hepatitis C antibodies (anti‐ HCV) among multitransfused patients was studied and compared with predicted values obtained from a post‐transfusion hepatitis study and from data on the prevalence of anti‐HCV among blood donors. The prevalence of hepatitis B core antibodies (anti‐HBc) was also studied to determine the routes of transmission of hepatitis C virus. The patients consisted of 65 dialysis patients (57 on haemodialysis and 8 on continuous ambulatory peritoneal dialysis) and 71 leukemia patients in long‐term remission [49 with acute myeloid leukemia (AML) and 22 with acute lymphatic leukemia (ALL)]. The presence of anti‐HCV was investigated using a second generation enzyme‐linked immunosorbent assay. Reactive samples were confirmed by a second generation recombinant immunoblot assay. Anti‐HBc was studied in the 65 dialysis patients and in 40 of the leukemia patients. Three (4.6%) of the 65 dialysis patients and 12 (24.5%) of the 49 AML patients were anti‐HCV positive whereas all of the ALL patients were seronegative. The total number of blood units transfused to 134 patients (data on two dialysis patients were not available) was 18,148, out of which 17,575 units had been transfused prior to the initiation of anti‐ HCV screening of blood donors. On the basis of the anti‐HCV prevalence among blood donors and the incidence of post‐transfusion hepatitis, the predicted number of seropositive patients was 11 and 18, respectively. Five of the 65 dialysis patients were anti‐HBc positive, compared with only one of the 40 leukemia patients. It is concluded that the anti‐HCV prevalence among dialysis and leukemia patients is concordant with the risk of receiving contaminated blood products, whereas hepatitis B infection may have other routes of transmission in dialysis patients. © 1993 Wiley‐Liss, Inc.</jats:p>